Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Golec

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|November 19, 2008
Measuring US pharmaceutical industry R&D spendingJoseph Golec, John Vernon
Applied Health Economics and Health Policy|October 6, 2009
Financial risk of the biotech industry versus the pharmaceutical industryJoseph Golec, John A Vernon
Health Economics|April 28, 2017
How excluding some benefits from value assessment of new drugs impacts innovationJoseph P Cook, Joseph Golec
Pharmacoeconomics|July 13, 2010
Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firmsJoseph Golec, John A Vernon
Pharmacoeconomics|October 7, 2009
Economic evaluation and cost-effectiveness thresholds: signals to firms and implications for R & D investment and innovationJohn A Vernon, Robert Goldberg, Joseph Golec
The Review of Scientific Instruments|January 14, 2025
Design and implementation of optics for the experiment for cryogenic large-aperture intensity mapping (EXCLAIM)Thomas Essinger-Hileman, Danny Chmaytelli, Trevor Oxholm, et al.
Applied Optics|January 6, 2023
Simons Observatory: characterizing the Large Aperture Telescope Receiver with radio holographyGrace E Chesmore, Kathleen Harrington, Carlos E Sierra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|November 19, 2008
Measuring US pharmaceutical industry R&D spendingJoseph Golec, John Vernon
Applied Health Economics and Health Policy|October 6, 2009
Financial risk of the biotech industry versus the pharmaceutical industryJoseph Golec, John A Vernon
Health Economics|April 28, 2017
How excluding some benefits from value assessment of new drugs impacts innovationJoseph P Cook, Joseph Golec
Pharmacoeconomics|July 13, 2010
Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firmsJoseph Golec, John A Vernon
Pharmacoeconomics|October 7, 2009
Economic evaluation and cost-effectiveness thresholds: signals to firms and implications for R & D investment and innovationJohn A Vernon, Robert Goldberg, Joseph Golec
The Review of Scientific Instruments|January 14, 2025
Design and implementation of optics for the experiment for cryogenic large-aperture intensity mapping (EXCLAIM)Thomas Essinger-Hileman, Danny Chmaytelli, Trevor Oxholm, et al.
Applied Optics|January 6, 2023
Simons Observatory: characterizing the Large Aperture Telescope Receiver with radio holographyGrace E Chesmore, Kathleen Harrington, Carlos E Sierra, et al.
Pageof 1